News & Updates

Treatment with datopotamab deruxtecan (Dato-DXd), an investigational TROP2*-directed antibody-drug conjugate, significantly improves progression-free survival (PFS) in patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer, according to the TROPION-Breast01 trial presented at ESMO 2023.

Research in a multiethnic cohort of older adults in Singapore has shown that hearing impairment (HI) is terrible for the quality of life (QoL).

The integrated structure HaH Buddy enables the delivery of hospital care at home, fulfilling the physical, spatial, and interpersonal needs of patients at an affordable price, according to a Singapore study.

Raman spectroscopy may be a clinically powerful diagnostic tool for real-time in vivo staging of nasopharyngeal cancer (NPC) during endoscopy, a study from Singapore has shown.

In the treatment of critically ill patients with COVID-19, simvastatin is not necessarily better than standard of care in terms of improving organ support-free days and death outcomes, according to a study.